Xingwang Sun
Luzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Correction: ADORA2A promotes proliferation and inhibits apoptosis through PI3K/AKT pathway activation in colorectal carcinoma.
Journal: Scientific reports
Published: December 09, 2025
Non-endoscopic Screening for Esophageal Squamous Cell Carcinoma: Recent Advances.
Journal: Journal of gastrointestinal cancer
Published: October 19, 2023
Cytoplasmic poly(A)-binding protein 1 as a biomarker to assist early diagnosis and prognosis of esophageal squamous cell carcinoma in endoscopic biopsy fragments.
Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
Published: April 03, 2023
Silencing MARCH2 Inhibits the Invasion, Migration, and EMT Transformation of Human Colorectal Cancer SW480 Cells.
Journal: Technology in cancer research & treatment
Published: March 24, 2023
Correction: Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy.
Journal: BMC cancer
Published: February 28, 2023
Correlation of INHBA Overexpression with Pathological Features, Antitumor Immune Response and Clinical Prognosis in Cervical Cancer.
Journal: Medicina (Kaunas, Lithuania)
Published: November 17, 2022
Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy.
Journal: BMC cancer
Published: August 02, 2022
Long noncoding RNA CLAN promotes lymphangiogenesis in the colorectal carcinoma.
Journal: Virchows Archiv : an international journal of pathology
Published: July 11, 2022
C5aR1 promotes the progression of colorectal cancer by EMT and activating Wnt/β-catenin pathway.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: June 27, 2022
Expression of Polyadenylate-binding Protein Cytoplasmic 1 (PABPC1) in Combination With RAD51 as Prognostic Biomarker in Patients Who Underwent Postoperative Chemotherapy for Esophageal Squamous Cell Carcinoma.
Journal: Applied immunohistochemistry & molecular morphology : AIMM
Published: April 23, 2022
Prevalence of targeted therapy-related genetic variations in NSCLC and their relationship with clinicopathological characteristics.
Journal: PloS one
Published: October 01, 2021
Last Updated: 09/26/2026